SynRec Team Visits Iran Health Exhibition to Explore Innovations in Mental Health Technologies

As part of its ongoing commitment to scientific advancement and innovation, members of the SynRec leadership team visited the Iran Health Exhibition 2025 to stay up to date with the latest developments in medical technology and healthcare solutions.

Sara Rezvan, Chief Technology Officer (CTO), and Shila Kia, Chief Financial Officer (CFO), attended the exhibition to explore cutting-edge tools and emerging trends that could support the ongoing development of SynRec’s AI-based diagnostic platform for mental health disorders.

SynRec is currently focused on developing an advanced artificial intelligence technique for analyzing EEG and fMRI data to assist in the early detection of psychological conditions such as Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD). By identifying neurological biomarkers through deep learning algorithms, the project aims to provide a more objective and earlier diagnostic alternative to traditional clinical assessments.

The Iran Health Exhibition offered valuable insights into related technologies and potential collaborations that could enhance the technical and clinical aspects of SynRec’s ongoing research and development efforts.